Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025

Kainos Medicine Revenue

In the year 2025, Kainos Medicine had annual revenue of 1.17B KRW with 98.46% growth. Kainos Medicine had revenue of 304.09M in the quarter ending December 31, 2025, with 326.34% growth.

Revenue
1.17B
Revenue Growth
+98.46%
P/S Ratio
30.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.56B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.17B581.27M98.46%
Dec 31, 2024590.37M323.05M120.85%
Dec 31, 2023267.31M137.29M105.59%
Dec 31, 2022130.02M-1.53B-92.18%
Dec 31, 20211.66B--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Eutilex.Co.,Ltd 10.29B
Epibiotech 449.62M
MOA Life Plus 11.22B
NGeneBio 21.24B
Moogene Medi 12.95M
Poongjeon Pharmacy CO.,LTD. 1.54B
Parataxis Korea 9.00M
J2KBIO 32.97B
Revenue Rankings